Tuesday, 23rd of April 2013 |
· AGE APPROPRIATE VACCINATION AGAINST MEASLES AND DPT 3 IN INDIA – CLOSING THE GAPS
· http://www.measlesupdates.org/?content=com_articles&artid=1666
· NON-SPECIFIC EFFECTS OF STANDARD MEASLES VACCINE AT 4.5 AND 9 MONTHS OF AGE ON CHILDHOOD MORTALITY: RANDOMIZED CLINICAL TRIAL
· http://www.measlesupdates.org/?content=com_articles&artid=1664
· IMMUNOLOGICAL IMPACT OF AN ADDITIONAL EARLY MEASLES VACCINE IN GAMBIAN CHILDREN: RESPONSE TO A BOOSTER
· http://www.measlesupdates.org/?content=com_articles&artid=1665
· PROTECTIVE EFFICACY OF STANDARD EDMONSTON-ZAGREB MEASLES VACCINATION IN INFANTS AGED 4.5 MONTHS: INTERIM ANALYSIS OF A RANDOMIZED CLINICAL TRIAL
· http://www.measlesupdates.org/?content=com_articles&artid=1663
Are three drugs for malaria better than two?
Friday, 24th of April 2020 |
Public health Interventions and epidemic intensity during the 1918 influenza pandemic
Thursday, 16th of April 2020 |
Chloroquine and hydroxychloroquine as available weapons to fight COVID-19
Tuesday, 17th of March 2020 |
Using models to shape measles control and elimination strategies in low- and middle-income countries: A review of recent applications
Monday, 17th of February 2020 |
Immunization Agenda 2030
Tuesday, 11th of February 2020 |
41187000 |
www.measlesinitiative.org www.technet21.org www.polioeradication.org www.globalhealthlearning.org www.who.int/bulletin allianceformalariaprevention.com www.malariaworld.org http://www.panafrican-med-journal.com/ |